Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.

Vernal keratoconjunctivitis (VKC) is an ocular disorder characterized by severe inflammation affecting both the cornea and ...

Its success is heavily reliant on products like VTAMA, currently approved for psoriasis and under investigation for atopic ...

Atopic dermatitis (AD), commonly referred to as eczema ... Do not use VTAMA cream in your eyes, mouth, or vagina. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in subjects treated ...

The company said patients in the study who had discontinued dupilumab due to eye-related events ... years and older with moderate-to-severe atopic dermatitis that is not well controlled with ...

Atopic dermatitis (AD), commonly referred to as eczema ... Do not use VTAMA cream in your eyes, mouth, or vagina. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in subjects ...

Shahnaz HusainIndia's air pollution levels are rising. The seasonal spike combined with pollutants emitted by factories, cars, construction materials and seasonal agriculture practices like crop stubb ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

A family-friendly concept is highlighted at the China International Import Expo, ranging from disease care, driving safety ...

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...